Log In Sign Up Premium
#1 AI Stock to Buy
  • Markets
    • News
    • Tech
    • Market Movers
    • Futures Forex
    • Macroeconomic Predictions
    • Economy
    • Industries
    • Options
  • Insider Trading
    • Main
    • Education Center
    • Insider Trading Screener
    • Insider Purchases
    • Insider Sales
    • Browse Companies
    • Transcripts
    • Latest 13D & 13G Filings
  • Hedge Funds
    • Main
    • Education Center
    • Browse Hedge Funds
    • Investor Letters
    • Best Performing
    • Worst Performing
    • Other Institutional Investors
  • Retirement
    • ETF Trading
    • Commodities
    • Gold
    • Dividend Stocks
  • Opinion
    • Main
    • Hedge Fund Analysis
    • Stock Analysis
    • We Disagree
    • Lists
    • Authors
  • Premium
    • Newsletters
    • My Subscriptions
    • Premium Readership
  • Log In
  • Sign Up

Our #1 AI Stock Pick — 33% OFF: $9.99 (was $14.99)  Monthly picks · Ad-free browsing · 30-day money back guarantee

Our #1 AI Stock Pick — 33% OFF: $9.99 (was $14.99)  Monthly picks · Ad-free browsing

Unlock Now — $9.99
Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for Sorry, no results has been found matching your query.

Insider Monkey Blog

Ambarella (AMBA) Grew 2Q Revenue 13.2% and Signed 7-Year Channel Agreements. Can Edge-AI Scale Reverse Margin Compression?

Ambarella, Inc. (NASDAQ:AMBA) reported fiscal second-quarter 2027 revenue of $108.1 million, up 13.2% from $95.5 million a year earlier.

Keep Reading →

September 4 - Hedge Funds, News

Jim Cramer Bullish on MP Materials (MP) But Warns Investors Not to Expect Quick Results

A caller inquired about starting a position in MP Materials Corp.

Keep Reading →

September 4 - News

Concrete Pumping (BBCP) Raised Outlook and Initiated a Dividend After Revenue Growth. Can Infrastructure Demand Fund Returns and Deleveraging?

Concrete Pumping Holdings, Inc. (NASDAQ:BBCP) reported fiscal third-quarter revenue of $116.8 million, up 12.6%, as U.S.

Keep Reading →

September 4 - Hedge Funds, News

ChronoScale Says It Plans a 50 MW Microsoft AI Deployment. Can CHRN Fund the Build Without Diluting Shareholders?

ChronoScale said on August 27 that it plans with Microsoft to deploy 50 megawatts of AI infrastructure in North America using NVIDIA GB300 NVL72 systems and liquid cooling.

Keep Reading →

September 4 - News, Stock Analysis

AWS Plans 2 Million More NVIDIA GPUs. Is This Better News for AMZN’s Cloud Growth or NVDA’s Backlog?

AWS and NVIDIA said on August 26 that Amazon's cloud plans to deploy two million additional Blackwell Ultra, Rubin, and Rubin Ultra GPUs during 2027 and 2028.

Keep Reading →

September 4 - News, Stock Analysis

Entergy Says Google’s Arkansas Solar Payments Could Total $2.1 Billion. Is Power Becoming Alphabet’s New Bottleneck?

Newly reported records put dollar figures on power infrastructure for Google's West Memphis data center, but Entergy says the first $716 million headline understated the full ...

Keep Reading →

September 4 - News, Stock Analysis

Jim Cramer Discussed The Big Excitement At Gap Inc. (NYSE:GAP)

Apparel retailer Gap Inc. (NYSE:GAP) reported its second quarterearnings on August 27th.

Keep Reading →

September 4 - News

Marvell Raised Its Outlook but Fell as Google Chip Revenue Stayed Distant. Has the AI Payoff Been Priced In? (Ready for review)

Marvell raised its annual forecasts on August 27, yet its shares fell as investors focused on the timing of revenue from a custom AI-chip relationship with Google.

Keep Reading →

September 4 - News, Stock Analysis

Jim Cramer Thinks This Struggling Stock Could See A “Big Earnings Acceleration”

Human resources and financial software provider Workday, Inc. (NASDAQ:WDAY)'s shares are down by more than 10% over the past year and by more than 3% year-to-date.

Keep Reading →

September 4 - News

Jim Cramer Revealed Why Ross Stores, Inc. (NASDAQ:ROST) Is “Kicking Butt”

Off price retailers The TJX Companies, Inc. (NYSE:TJX) and Ross Stores, Inc. (NASDAQ:ROST) have started to consistently appear on Jim Cramer's radar.

Keep Reading →

September 4 - News

Jim Cramer Might Have Revealed A Major Hidden Nuclear Stock As Part Of His Discussion Of Materials & Chemical Companies

Materials firm Solstice Advanced Materials, Inc.

Keep Reading →

September 4 - News

Coatue Opened Positions in Intel and Cerebras. Is the AI Chip Trade Broadening Beyond NVIDIA?

Coatue Management's Q2 filing disclosed a new position in Intel and, for the first time, a reportable position in newly public Cerebras.

Keep Reading →

September 4 - News, Stock Analysis

Jim Cramer Flagged Another Risk For Adobe Inc. (NASDAQ:ADBE)

Alphabet Inc. (NASDAQ:GOOGL) and Adobe Inc. (NASDAQ:ADBE) are different firms whose businesses overlap.

Keep Reading →

September 4 - News

Jim Cramer Says “Someone Must Know Something” About Broadcom Inc. (NASDAQ:AVGO)’s Post-Earnings Share Dip

Broadcom Inc. (NASDAQ:AVGO) dipped on September 3rd, the day after the firm reported its fiscal third quarter earnings report.

Keep Reading →

September 4 - News

Jim Cramer Couldn’t Stop Gushing About This Computer Hardware AI Stock

Computer hardware firm Dell Technologies Inc. (NYSE:DELL)'s shares closed 15.8% higher the day after the firm reported its second fiscal quarter earnings report.

Keep Reading →

September 4 - News

CrowdStrike and Palo Alto Made the SaaSmageddon Survivor List. Can AI Expand Their Moats Faster Than It Compresses Software Prices?

An August 25 analysis of so-called SaaSmageddon survivors included CrowdStrike and Palo Alto Networks, arguing that security platforms may resist AI-driven software disruption...

Keep Reading →

September 4 - News, Stock Analysis

There Are A Lot Of Zscaler Inc. (NASDAQ:ZS) Shorts, Says Jim Cramer

Cybersecurity firm Zscaler Inc. (NASDAQ:ZS)'s shares were lower in pre market trading the day the firm reported its fiscal fourth quarter earnings report.

Keep Reading →

September 4 - News

Jim Cramer Said Meta Platforms, Inc. (NASDAQ: META)’s Big Court Win Was A Close Call

For more than a year, Jim Cramer has been quite favorable about Meta Platforms, Inc. (NASDAQ: META).

Keep Reading →

September 4 - News

TiVo OS Added Generative AI Discovery. Can Xperi Take Share From Roku Without Owning the TV Screen?

Xperi used the IFA trade show on September 3 to unveil major TiVo OS updates, including a forthcoming Agent TiVo feature for natural-language discovery.

Keep Reading →

September 4 - News, Stock Analysis

Jim Cramer Discussed A Little Known Chip Stock That He Likes

Qnity Electronics, Inc. (NYSE:Q) is a chemicals and materials firm that caters to the needs of the semiconductor and electronics industries.

Keep Reading →

September 4 - News

Jim Cramer Believes Nvidia Corp. (NASDAQ:NVDA) Buying Back Half A Trillion Worth In Stock Would Be Great

Nvidia Corp. (NASDAQ:NVDA)'s shares are up by 22% year-to-date as their performance has remained muted after posting major gains in the previous years.

Keep Reading →

September 4 - News

NetApp Raised Guidance as Ciena’s Revenue Jumped 37%. Are AI Networks and Storage Finally Converting Into Earnings?

NetApp and Ciena delivered unusually strong results within a day of each other.

Keep Reading →

September 4 - News, Stock Analysis

Jim Cramer Left Intrigued By Lululemon Athletica Inc. (NASDAQ:LULU)’s “Self Destruction”

Athletic apparel retailer Lululemon Athletica Inc. (NASDAQ:LULU)'s shares were decimated on the 4th as they closed a whopping 17.4% lower.

Keep Reading →

September 4 - News

Jim Cramer Is Excited About These Two Cybersecurity Stocks

Palo Alto Networks, Inc. (NASDAQ:PANW) and CrowdStrike Holdings, Inc. (NASDAQ:CRWD) continue to be part of one of Jim Cramer's favorite technology sectors, cybersecurity.

Keep Reading →

September 4 - News

Nasdaq Bought an AI Due-Diligence Platform as ICE Built Private-Credit Intelligence. Which Data Moat Is Deeper?

Nasdaq completed its acquisition of Dasseti on September 2, adding an AI-assisted due-diligence and monitoring platform to Nasdaq eVestment.

Keep Reading →

September 4 - News, Stock Analysis

Ambarella Beat Estimates but Fell as NXP Buyout Talk Lingered. Is the Edge-AI Upside Already Priced In?

Ambarella reported fiscal Q2 revenue of $108.1 million, up 13.2% year over year, and adjusted earnings of $0.18 per share versus $0.17 expected.

Keep Reading →

September 4 - News, Stock Analysis

PlusAI Picked a SPAC to Fund Its 2027 Autonomous-Truck Launch. Is Aurora Already Too Far Ahead?

PlusAI and Texas Ventures Acquisition III announced a SPAC transaction on September 3 designed to fund PlusAI's planned 2027 commercial autonomous-truck launch.

Keep Reading →

September 4 - News, Stock Analysis

Jim Cramer Shares a Cautious Take on Oracle (ORCL) and Its Massive AI Buildout

On September 2, a caller pointed to market anxiety over Oracle Corporation’s (NYSE:ORCL) data center loans and asked if rising moratoria and negative sentiment surrounding data...

Keep Reading →

September 4 - News

Quanex (NX) Expanded 3Q Margins and Repaid $42M of Debt on 1.3% Sales Growth. Can Execution Outrun Soft Volumes?

Quanex Building Products Corporation (NYSE:NX) reported fiscal third-quarter net sales of $501.8 million, up 1.3% from $495.3 million a year earlier.

Keep Reading →

September 4 - Hedge Funds, News

Pasqal (PSQL) Has $360M to Scale From Seven Quantum Systems. Is €16.5M of Revenue Enough to Support the Road Map?

Pasqal Holding SA (NASDAQ:PSQL) enters the public market with installed hardware and recognized commercial revenue, two things many early quantum-computing businesses lack.

Keep Reading →

September 4 - Hedge Funds, News

Jim Cramer Highlights AeroVironment’s (AVAV) Steep Competition

During the lightning round of the September 2 episode, a caller asked if AeroVironment, Inc. (NASDAQ:AVAV) stock being down presents a good buying opportunity.

Keep Reading →

September 4 - News

Tenax (TENX) Found a 26.3-Meter Benefit in a Prespecified Subgroup After LEVEL Missed Its Primary Endpoint. Is Another Phase 3 Trial Viable?

Tenax Therapeutics, Inc. (NASDAQ:TENX) has a possible route forward for TNX-103, but the Phase 3 LEVEL trial did not establish efficacy in the overall population.

Keep Reading →

September 4 - Hedge Funds, News

Xenon (XENE) Heads To Europe With Data That Could Reshape Epilepsy Care

On August 26, Xenon Pharmaceuticals (NASDAQ:XENE) announced that it will deliver six data presentations at the 16th European Epilepsy Congress in Athens, Greece, running September...

Keep Reading →

September 4 - Hedge Funds, News

Construction Partners (ROAD) Doubles Down On Oklahoma’s Asphalt Supply Chain

On August 31, Construction Partners (NASDAQ:ROAD) closed its purchase of Asphalt Express Enterprises, a liquid asphalt supply and hauling business based in Ardmore, Oklahoma.

Keep Reading →

September 4 - Hedge Funds, News

Amneal Pharmaceuticals (AMRX) Bets Big On Biosimilars While Wall Street Retreats

On August 10, Amneal Pharmaceuticals (NASDAQ:AMRX) completed its acquisition of Kashiv BioSciences, a deal that co-CEO Chirag Patel called a pivotal step in the company's push...

Keep Reading →

September 4 - Hedge Funds, News

Postal Realty (PSTL) Earned a BBB Rating. Can Lower Funding Costs Accelerate USPS Property Consolidation?

Postal Realty Trust, Inc.

Keep Reading →

September 4 - Hedge Funds, News

BeOne (ONC) Secured a Pharmaceutical-Tariff Exemption After More than $1B of U.S. Manufacturing Investment. Are the Pricing Concessions Worth It?

BeOne Medicines AG (NASDAQ:ONC) entered a voluntary agreement with the U.S.

Keep Reading →

September 4 - Hedge Funds, News

FDA Fast Track Puts Erasca’s (ERAS) Pancreatic Bet Center Stage

On August 24, Erasca (NASDAQ:ERAS) announced that the FDA had granted Fast Track Designation to ERAS-0015, its oral pan-RAS molecular glue, for patients with metastatic pancreatic...

Keep Reading →

September 4 - Hedge Funds, News

Stryker (SYK) is Buying ZuriMED. Can FiberLocker Strengthen its Shoulder Portfolio?

Stryker Corporation (NYSE:SYK) signed a definitive agreement to acquire privately held ZuriMED, which would add the commercialized FiberLocker System to its shoulder portfolio...

Keep Reading →

September 4 - Hedge Funds, News

Array (ARRY) Says its AWM Acquisition Will Be High-Single-Digit Accretive. How Much Depends on Cross-Selling?

Array Technologies, Inc.

Keep Reading →

September 4 - Hedge Funds, News

Commvault (CVLT) Turns Cyberattacks Into Automated Recovery Through New CrowdStrike (CRWD) Deal

On August 31, Commvault (NASDAQ:CVLT) announced that its cyber recovery actions can now run as native steps inside CrowdStrike Holdings' (NASDAQ:CRWD) Charlotte Agentic SOAR workflows...

Keep Reading →

September 4 - Hedge Funds, News

Commvault’s (CVLT) AI Recovery Bet Meets A Margin Reality Check

On August 3, Commvault (NASDAQ:CVLT) plugged Google's threat intelligence directly into the recovery workflows customers use after a cyberattack, a small-sounding update that ...

Keep Reading →

September 4 - Hedge Funds, News

Americold (COLD) Raised $1.1B by Contributing 12 Warehouses to a Joint Venture. Is Deleveraging Worth Ceding 70% of the Economics?

Americold Realty Trust, Inc. (NYSE:COLD) completed a cold-storage joint venture with EQT’s Active Core Infrastructure fund covering 12 U.S.

Keep Reading →

September 4 - Hedge Funds, News

Commvault (CVLT) Triples Its Cloud Safety Net While Wall Street Cools

On August 18, Commvault (NASDAQ:CVLT) expanded its Cloud Rewind platform, tripling the number of Microsoft Azure resource types it can protect and recover after a cyberattack ...

Keep Reading →

September 4 - Hedge Funds, News

Jazz (JAZZ) Says Ziihera Beat Trastuzumab on Overall Survival. Can it Replace the First-Line HER2 Backbone?

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) reported that Ziihera plus chemotherapy produced a statistically significant and clinically meaningful overall-survival benefit over trastuzumab...

Keep Reading →

September 4 - Hedge Funds, News

Zegna’s (ZGN) Direct Sales Surge Can’t Fully Offset A Messier Profit

On September 3, Ermenegildo Zegna Group (NYSE:ZGN) reported first-half revenues of €987.3 million, up 6.4% year over year and 9.3% on an organic basis.

Keep Reading →

September 4 - Hedge Funds, News

Revolution Med (RVMD) Priced Rasonque at $39,800 per 30-Day Supply. Can Access Match the Clinical Breakthrough?

Revolution Medicines, Inc. (NASDAQ:RVMD) received FDA approval for Rasonque, or daraxonrasib, following an expedited review.

Keep Reading →

September 4 - Hedge Funds, News

Hormel (HRL) Expanded Adjusted Operating Margin Despite a Volume Decline. Can Cost Savings Carry the Turnaround?

Hormel Foods Corporation (NYSE:HRL) reported fiscal third-quarter sales of $2.96 billion, down 2.4%, as volume declined 7.4% and organic net sales fell 1.7%.

Keep Reading →

September 4 - Hedge Funds, News

Murphy Oil (MUR) Strikes Black Gold While Profits Multiply Tenfold

On August 5, Murphy Oil Corporation (NYSE:MUR) reported second-quarter results that showed the company hitting on nearly every cylinder at once.

Keep Reading →

September 4 - Hedge Funds, News

Science Applications (SAIC) Grew Revenue 6% but Posted a 0.6 Book-to-Bill Ratio. Is the $22B Backlog Enough?

Science Applications International Corporation (NASDAQ:SAIC) reported second-quarter fiscal 2027 revenue of $1.88 billion, up 6.3% year over year.

Keep Reading →

September 4 - Hedge Funds, News

« Older Entries
Hedge Fund Resource Center Hedge Fund Resource Center
  • How to Best Use Insider Monkey to Increase Your Returns
  • Why Track Hedge Funds?
  • Download a Free Edition!
  • Why You Should DUMP Your Hedge Funds
  • 6 Things You Didn't Know About Hedge Funds
Hot Topics

Apple (AAPL)

Latest Stock News - Company Profile

Warren Buffett

News & Analysis - Portfolio & Stock Picks

Biggest Insider Purchases & Sales

News & Analysis - Data Screener

Google (GOOG)

Latest Stock News - Company Profile

Microsoft (MSFT)

Latest Stock News - Company Profile

Lists

11 Largest Uranium Producing Countries in the World

11 Largest Uranium Producing Countries in the World

12 Fastest Declining Economies in the World in 2026

12 Fastest Declining Economies in the World in 2026

10 Most Popular Stocks on Robinhood in 2026

10 Most Popular Stocks on Robinhood in 2026

9 Undervalued Chemical Stocks to Buy According to Hedge Funds

9 Undervalued Chemical Stocks to Buy According to Hedge Funds

7 Most Promising Psychedelic Stocks According to Hedge Funds

7 Most Promising Psychedelic Stocks According to Hedge Funds

7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds

7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds

15 Innovative Healthcare Stocks to Buy According to Analysts

15 Innovative Healthcare Stocks to Buy According to Analysts

9 High Growth Small Cap Stocks That Are Profitable

9 High Growth Small Cap Stocks That Are Profitable

20 Most Profitable Stocks of the Last 20 Years

20 Most Profitable Stocks of the Last 20 Years

15 High Growth Mid-Cap Stocks to Buy

15 High Growth Mid-Cap Stocks to Buy

Top 10 Oncology Stocks to Buy Now

Top 10 Oncology Stocks to Buy Now

10 Best Investments During A Recession

10 Best Investments During A Recession

7 Best Rare Earth Stocks to Buy According to Hedge Funds

7 Best Rare Earth Stocks to Buy According to Hedge Funds

Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending

Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending

New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST)

New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST)

J.P. Morgan Lifts Natera, Inc. (NTRA) Target on Signatera Momentum

J.P. Morgan Lifts Natera, Inc. (NTRA) Target on Signatera Momentum

11 Best Cancer Stocks to Buy Right Now

11 Best Cancer Stocks to Buy Right Now

Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut

Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut

20 Countries with the Highest Homeless Population

20 Countries with the Highest Homeless Population

12 Countries with the Highest Bond Yields in the World

12 Countries with the Highest Bond Yields in the World

20 Countries with the Most Battle Tanks in the World

20 Countries with the Most Battle Tanks in the World

12 Best Nasdaq Stocks Under $20 to Buy Now

12 Best Nasdaq Stocks Under $20 to Buy Now

10 Best Low Beta Tech Stocks to Buy According to Analysts

10 Best Low Beta Tech Stocks to Buy According to Analysts

10 Worst Performing Currencies of 2024

10 Worst Performing Currencies of 2024

16 Countries with the Largest Proven Oil Reserves in the World

16 Countries with the Largest Proven Oil Reserves in the World

16 Highest Quality Chocolate Brands in the US

16 Highest Quality Chocolate Brands in the US

20 Countries with the Strongest Armies in the World

20 Countries with the Strongest Armies in the World

Top 13 English Speaking Countries in Asia

Top 13 English Speaking Countries in Asia

20 States with Highest Female to Male Ratio in the US

20 States with Highest Female to Male Ratio in the US

20 States with the Lowest Life Expectancy in the US

20 States with the Lowest Life Expectancy in the US

25 Cities with the Highest Homeless Population in the World

25 Cities with the Highest Homeless Population in the World

30 Cities with the Highest Weed Consumption in the US

30 Cities with the Highest Weed Consumption in the US

25 Countries with the Highest Alcohol Consumption per Capita

25 Countries with the Highest Alcohol Consumption per Capita

10 Best Gold Stocks Under $30

10 Best Gold Stocks Under $30

10 Best Genomics Stocks To Buy Right Now

10 Best Genomics Stocks To Buy Right Now

Get our editor’s daily picks straight in your inbox!

RSS Feed Hedge Funds Insider Trading About Us Authors Contact Us Sitemap
Privacy Policy Terms of Use Disclosure Policy FAQ CCPA - Do Not Sell My Information. ©2026 Koala Guide LLC.